Dietary factors and epigenetic regulation for prostate cancer prevention
- PMID: 22332092
- PMCID: PMC3226387
- DOI: 10.3945/an.111.001032
Dietary factors and epigenetic regulation for prostate cancer prevention
Abstract
The role of epigenetic alterations in various human chronic diseases has gained increasing attention and has resulted in a paradigm shift in our understanding of disease susceptibility. In the field of cancer research, e.g., genetic abnormalities/mutations historically were viewed as primary underlying causes; however, epigenetic mechanisms that alter gene expression without affecting DNA sequence are now recognized as being of equal or greater importance for oncogenesis. Methylation of DNA, modification of histones, and interfering microRNA (miRNA) collectively represent a cadre of epigenetic elements dysregulated in cancer. Targeting the epigenome with compounds that modulate DNA methylation, histone marks, and miRNA profiles represents an evolving strategy for cancer chemoprevention, and these approaches are starting to show promise in human clinical trials. Essential micronutrients such as folate, vitamin B-12, selenium, and zinc as well as the dietary phytochemicals sulforaphane, tea polyphenols, curcumin, and allyl sulfur compounds are among a growing list of agents that affect epigenetic events as novel mechanisms of chemoprevention. To illustrate these concepts, the current review highlights the interactions among nutrients, epigenetics, and prostate cancer susceptibility. In particular, we focus on epigenetic dysregulation and the impact of specific nutrients and food components on DNA methylation and histone modifications that can alter gene expression and influence prostate cancer progression.
Conflict of interest statement
Author disclosures: E. Ho, L. M. Beaver, D. E. Williams, and R. H. Dashwood, no conflicts of interest.
Figures


Similar articles
-
Cancer chemoprevention by targeting the epigenome.Curr Drug Targets. 2011 Dec;12(13):1925-56. doi: 10.2174/138945011798184155. Curr Drug Targets. 2011. PMID: 21158707 Review.
-
Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.Top Curr Chem. 2013;329:73-132. doi: 10.1007/128_2012_360. Top Curr Chem. 2013. PMID: 22955508 Review.
-
Dietary Plant Metabolites Induced Epigenetic Modification as a Novel Strategy for the Management of Prostate Cancer.Mini Rev Med Chem. 2024;24(15):1409-1426. doi: 10.2174/0113895575283895240207065454. Mini Rev Med Chem. 2024. PMID: 38385496 Review.
-
Combinatorial Epigenetics Impact of Polyphenols and Phytochemicals in Cancer Prevention and Therapy.Int J Mol Sci. 2019 Sep 14;20(18):4567. doi: 10.3390/ijms20184567. Int J Mol Sci. 2019. PMID: 31540128 Free PMC article. Review.
-
Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms.Cancers (Basel). 2023 Jan 23;15(3):697. doi: 10.3390/cancers15030697. Cancers (Basel). 2023. PMID: 36765652 Free PMC article. Review.
Cited by
-
Benefits of Selenium Supplementation on Leukocyte DNA Integrity Interact with Dietary Micronutrients: A Short Communication.Nutrients. 2016 Apr 27;8(5):249. doi: 10.3390/nu8050249. Nutrients. 2016. PMID: 27128937 Free PMC article.
-
Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells.Cancer Lett. 2013 Sep 1;337(2):177-83. doi: 10.1016/j.canlet.2013.05.014. Epub 2013 May 16. Cancer Lett. 2013. PMID: 23684928 Free PMC article.
-
Higher maternal plasma folate, vitamin B12 and homocysteine levels in women with preeclampsia.J Hum Hypertens. 2019 May;33(5):393-399. doi: 10.1038/s41371-019-0164-4. Epub 2019 Jan 15. J Hum Hypertens. 2019. PMID: 30647465
-
Recent advances in the management of dry age-related macular degeneration: A review.F1000Res. 2017 Mar 9;6:245. doi: 10.12688/f1000research.10664.1. eCollection 2017. F1000Res. 2017. PMID: 28529701 Free PMC article. Review.
-
In nutrition, can we "see" what is good for us?Adv Nutr. 2013 May 1;4(3):327S-34S. doi: 10.3945/an.112.003558. Adv Nutr. 2013. PMID: 23674801 Free PMC article. Review.
References
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74 - PubMed
-
- Boumber Y, Issa JP. Epigenetics in cancer: what's the future? Oncology. 2011;25:220–6, 228 - PubMed
-
- Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433–40 - PubMed
-
- Dobosy JR, Roberts JLW, Fu VX, Jarrard DF. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J Urol. 2007;177:822–31 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA122959/CA/NCI NIH HHS/United States
- P01 CA090890/CA/NCI NIH HHS/United States
- CA90890/CA/NCI NIH HHS/United States
- R01 CA122906/CA/NCI NIH HHS/United States
- CA80176/CA/NCI NIH HHS/United States
- R29 CA065525/CA/NCI NIH HHS/United States
- R01 CA065525/CA/NCI NIH HHS/United States
- CA122906/CA/NCI NIH HHS/United States
- R01 CA122959/CA/NCI NIH HHS/United States
- CA65525/CA/NCI NIH HHS/United States
- P30 ES000210/ES/NIEHS NIH HHS/United States
- P30 ES00210/ES/NIEHS NIH HHS/United States
- R01 CA080176/CA/NCI NIH HHS/United States